Sitagliptin previously identified as MK-0431 and marketed as the phosphate salt under the trade name Januvia) is an oral antihyperglycemic (antidiabetic drug) of the dipeptidyl peptidase-4 (DPP-4) inhibitor class. It was developed, and is marketed, by Merck & Co.
API's & Drug Standards
|Appearance||white solid form|
Send us your enquiry for Sitagliptin Phosphate. We offer custom pack sizes at special prices. We aim to respond to your enquiry within 24 hours.
We value your input so if you have suggestions regarding new applications for Sitagliptin Phosphate email us and we will include your contribution on the website.